San Diego Business Journal

Amylin Watches Its R & D; Costs Continue to Rise
Neurogenetics Secures $10M In Series B Preferred Stock

BIOTECH
by Marion Webb, Senior Staff Writer

Amylin Pharmaceuticals, Inc...